Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.81−0.09 (-4.74%)
Close on Nov 18, 2026Market cap $18.06MP/E –Yield –
Atossa Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2014 it was $49.22K, up 745.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $49.22K | +745.6% |
| FY2013 | Dec 31, 2013 | $5.82K | – |
See a number that looks wrong?